Updated Jul 16, 2026
Coughlin Timothy has filed 6 SEC Form 4 filings across 4 companies in the last 90 days — selling. Lifetime open-market sales: $642K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 10.0K | $50.07 | $501K |
| 2026-06-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 10.0K | $26.52 | $265K |
| 2026-06-10 | VIR | Vir Biotechnology, Inc. | A — Grant or award | 8.0K | $0.00 | |
| 2026-06-10 | VIR | Vir Biotechnology, Inc. | A — Grant or award | 8.0K | $0.00 | |
| 2026-06-03 | ADCT | ADC Therapeutics SA | F — Tax withholding / forfeiture | 12.6K | $3.08 | $39K |
| 2026-06-03 | ADCT | ADC Therapeutics SA | A — Grant or award | 45.0K | $0.00 | |
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-05-19 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 3.2K | $43.49 | $141K |
Coughlin Timothy is a corporate insider — currently tracked as Insider of Travere Therapeutics, Inc. (TVTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
6 primary Form 4 filings in the last 90 days, covering 4 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($642K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Coughlin Timothy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.